Summit Therapeutics Inc. Cash Flows From Used In Investing Activities
Summit Therapeutics Inc. (SMMT) reported Cash Flows From Used In Investing Activities of -GBP 151.00 thousand for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2020-06-02
- Summit Therapeutics Inc. cash flows from used in investing activities for the quarter ending 2020-03-31 was -151.00K GBP.
- Summit Therapeutics Inc. cash flows from used in investing activities for the quarter ending 2019-10-31 was -13.00K GBP.
- Summit Therapeutics Inc. cash flows from used in investing activities for the quarter ending 2019-07-31 was -214.00K GBP.
- Summit Therapeutics Inc. cash flows from used in investing activities for the quarter ending 2019-04-30 was -2.00K GBP.
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 11 month | Cash Flows From Used In Investing Activities 12 month | Cash Flows From Used In Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-03-31 | -151.00K GBP 6-K · filed 2020-06-02 | |||||
| 2019-12-31 | -263.00K GBP 20-F · filed 2020-04-30 | |||||
| 2019-10-31 | -13.00K GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | -227.00K GBP derived: sum of 2 quarters · filed 2019-12-17 | -229.00K GBP 6-K · filed 2019-12-17 | |||
| 2019-07-31 | -214.00K GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -216.00K GBP 6-K · filed 2019-10-11 | ||||
| 2019-04-30 | -2.00K GBP 6-K · filed 2019-06-12 | |||||
| 2019-03-31 | -62.00K GBP 6-K · filed 2020-06-02 | |||||
| 2019-01-31 | -63.00K GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -68.00K GBP derived: sum of 2 quarters · filed 2020-04-30 | -92.00K GBP derived: sum of 3 quarters · filed 2020-04-30 | -121.00K GBP 20-F · filed 2020-04-30 | -313.00K GBP 20-F · filed 2019-03-29 | |
| 2018-10-31 | -5.00K GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | -29.00K GBP derived: sum of 2 quarters · filed 2019-12-17 | -58.00K GBP 6-K · filed 2019-12-17 | -4.90M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2018-07-31 | -24.00K GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -53.00K GBP 6-K · filed 2019-10-11 | -4.90M GBP derived: sum of 3 quarters · filed 2020-04-30 | -4.94M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2018-04-30 | -29.00K GBP 6-K · filed 2019-06-12 | -4.88M GBP derived: sum of 2 quarters · filed 2020-04-30 | -4.92M GBP derived: sum of 3 quarters · filed 2020-04-30 | -4.99M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2018-01-31 | -4.85M GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -4.89M GBP derived: sum of 2 quarters · filed 2020-04-30 | -4.96M GBP derived: sum of 3 quarters · filed 2020-04-30 | -5.24M GBP 20-F · filed 2020-04-30 | ||
| 2017-10-31 | -41.00K GBP derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | -117.00K GBP derived: sum of 2 quarters · filed 2018-12-11 | -396.00K GBP 6-K · filed 2018-12-11 | |||
| 2017-07-31 | -76.00K GBP derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | -355.00K GBP 6-K · filed 2018-09-20 | ||||
| 2017-04-30 | -279.00K GBP 6-K · filed 2018-06-05 | |||||
| 2017-01-31 | -80.00K GBP 20-F · filed 2019-03-29 | |||||
| 2016-01-31 | -36.00K GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |